EGFR activation observed in patients with NSCLC has two mechanisms: intrinsic activation caused by EGFR mutations and extrinsic activation by ligand recruitment in patients with wild-type EGFR [91]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.